Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Pumpkin seeds may improve health due to their rich nutrients and potential to treat various conditions.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Vitamin D may help regulate cholesterol and influence prostate cancer development.

Minoxidil can reduce functions related to androgen receptors.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

The meeting highlighted promising genetic treatments for male fertility issues but noted concerns about certain cancer risks and ICSI safety.

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

ERG increases SOX9, promoting prostate cancer growth and invasion.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

Dutasteride and finasteride affect different cell types differently.

WNT10B is linked to cancer development and affects survival and disease progression in various cancers.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

A new compound was effective for imaging prostate cancer in rats.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.